Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chee-Kiat Tan

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Expert Review of Gastroenterology & Hepatology|September 21, 2016
Peretinoin as an adjuvant therapy for hepatocellular carcinomaChee-Kiat Tan
Hepatology (Baltimore, Md.)|February 19, 2016
Incidence of hepatocellular carcinoma after seroclearance is not reducedChee-Kiat Tan
Annals of the Academy of Medicine, Singapore|August 22, 2014
Hepatitis--cure and preventionChee Kiat Tan
Alimentary Pharmacology & Therapeutics|May 17, 2024
Editorial: Has MetALD met the presumption?Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|August 13, 2024
Editorial: Quantity is important!Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|October 31, 2018
Editorial: hepatitis B, fatty liver, and metabolic syndrome-interaction or co-existence?Rajneesh Kumar, Chee-Kiat Tan
Indian Journal of Medical Sciences|July 9, 2009
Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinomaPik-Eu Chang, Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|June 28, 2019
Letter: impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues-further clarifications neededMiao-Shan Lim, Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|February 18, 2025
Editorial: Hyperferritinaemia-An Ironclad Biomarker for the Prognostication of MASLD?Mark C C Cheah, Chee-Kiat Tan
Journal of Digestive Diseases|February 17, 2016
Low serum albumin and advanced age predict early mortality in Asian patients with extreme elevations of serum aminotransferasePik Eu Chang, George Boon-Bee Goh, Chee Kiat Tan
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Expert Review of Gastroenterology & Hepatology|September 21, 2016
Peretinoin as an adjuvant therapy for hepatocellular carcinomaChee-Kiat Tan
Hepatology (Baltimore, Md.)|February 19, 2016
Incidence of hepatocellular carcinoma after seroclearance is not reducedChee-Kiat Tan
Annals of the Academy of Medicine, Singapore|August 22, 2014
Hepatitis--cure and preventionChee Kiat Tan
Alimentary Pharmacology & Therapeutics|May 17, 2024
Editorial: Has MetALD met the presumption?Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|August 13, 2024
Editorial: Quantity is important!Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|October 31, 2018
Editorial: hepatitis B, fatty liver, and metabolic syndrome-interaction or co-existence?Rajneesh Kumar, Chee-Kiat Tan
Indian Journal of Medical Sciences|July 9, 2009
Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinomaPik-Eu Chang, Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|June 28, 2019
Letter: impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues-further clarifications neededMiao-Shan Lim, Chee-Kiat Tan
Alimentary Pharmacology & Therapeutics|February 18, 2025
Editorial: Hyperferritinaemia-An Ironclad Biomarker for the Prognostication of MASLD?Mark C C Cheah, Chee-Kiat Tan
Journal of Digestive Diseases|February 17, 2016
Low serum albumin and advanced age predict early mortality in Asian patients with extreme elevations of serum aminotransferasePik Eu Chang, George Boon-Bee Goh, Chee Kiat Tan
Pageof 8